TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies [Yahoo! Finance]
TC BioPharm (Holdings) plc - American Depositary Shares (TCBP)
Company Research
Source: Yahoo! Finance
biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced the execution of a non-binding letter of intent as part of its M&A strategy aimed at expanding its therapeutic platform and leveraging NK (natural killer) cells in treating both solid tumors and other indications. The target asset acquisition covers the proprietary manufacturing process of two allogeneic CAR-NK therapeutics, both of which TCB believes are valuable as monotherapies as well as in conjunction with TCB-008 in the future. Initially, the CAR platforms both are targeted towards solid tumors, including a CD-70 CAR NK technology and an HER2 CAR-NK technology. TCB sees substantial synergies in this potential acquisition, both in clinical therapeutic terms of TCB-008 in combination with the CAR-NK assets, as well as leveraging the existing expertise and human capital of TCB to further advance and refine the manufacturing process while bringing in
Show less
Read more
Impact Snapshot
Event Time:
TCBP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TCBP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TCBP alerts
High impacting TC BioPharm (Holdings) plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TCBP
News
- COVID-19 Drug Pipeline Landscape Report 2024: Comprehensive Insights on 400+ Companies and 400+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
- TC Biopharm shares jump on signing non-binding LOI for two allogeneic CAR-NK therapeutics [Seeking Alpha]Seeking Alpha
- TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform TechnologiesPR Newswire
- TCBP Increasing Treatment Capacity with Expanded Manufacturing Process [Yahoo! Finance]Yahoo! Finance
- TCBP Increasing Treatment Capacity with Expanded Manufacturing ProcessPR Newswire
TCBP
Sec Filings
- 4/4/24 - Form 8-K
- 4/1/24 - Form 10-K
- 3/19/24 - Form 8-K
- TCBP's page on the SEC website